Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Oct. 2024, Reviewed, No invitation

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Feb. 2025, Reviewed, No invitation

Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis.
Kubo Satoshi, Siebuhr Anne Sofie, Bay-Jensen Anne-C, Juhl Pernille, Karsdal Morten A, Satoh Yurie, Todoroki Yasuyuki, Nakano Kazuhisa, Nakayamada Shingo, Tanaka Yoshiya
International journal of rheumatic diseases, Feb. 2020, Reviewed, No invitation

The two cases of acute acalculous cholecystitis associated with systemic lupus erythematosus (SLE) presented different clinical aspects
Satoh Y, Nakano K, Miyazaki Y, Nakayamada S, Fukuyo S, Kubo S, Miyagawa I, Yoshinari H, Saito K, Satoh M, Tanaka Y
Modern Rheumatology Case Reports, Jan. 2019, Reviewed, No invitation
Lead

The abundance of regulatory T cell subsets is associated with the clinical outcomes of sarcoidosis.
Kusaka Katsuhide, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Miyagawa Ippei, Satoh-Kanda Yurie, Todoroki Yasuyuki, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology, Apr. 2025, Reviewed, No invitation

Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.
Miyazaki Yusuke, Nakayamada Shingo, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Miyagawa Ippei, Satoh-Kanda Yurie, Todoroki Yasuyuki, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
RMD open, Jan. 2025, Reviewed, No invitation

Fine-tuning SLE treatment: the potential of selective TYK2 inhibition.
Satoh-Kanda Yurie, Nakayamada Shingo, Tanaka Yoshiya
RMD open, Dec. 2024, Reviewed, No invitation
Lead

Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.
Satoh-Kanda Yurie, Nakayamada Shingo, Kubo Satoshi, Yamagata Kaoru, Nawata Aya, Tanaka Hiroaki, Kosaka Shunpei, Kanda Ryuichiro, Yu Shan, Fujita Yuya, Sonomoto Koshiro, Tanaka Yoshiya
RMD open, Jun. 2024, Reviewed, No invitation
Lead

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto Koshiro, Nakayamada Shingo, Fujino Yoshihisa, Miyata Hiroko, Kubo Satoshi, Fujita Yuya, Inoue Yoshino, Matsunaga Satsuki, Iwata Shigeru, Hanami Kentaro, Todoroki Yasuyuki, Yoshinari-Korekoda Hiroko, Kawabe Akio, Yamaguchi Ayako, Ueno Masanobu, Satoh-Kanda Yurie, Kanda Ryuichiro, Funada Masashi, Ohkubo Naoaki, Kusaka Katsuhide, Kosaka Shumpei, Nagayasu Atsushi, Fukuyo Shunsuke, Nawata Masao, Miyazaki Yusuke, Tokunaga Mikiko, Tanaka Kenichi, Okada Yosuke, Tanaka Yoshiya
Rheumatology (Oxford, England), Nov. 2023, Reviewed, No invitation

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from FIRST registry.
Kubo Satoshi, Miyazaki Yusuke, Tanaka Hiroaki, Fujita Yuya, Sakai Hidenori, Ueno Masanobu, Todoroki Yasuyuki, Satoh-Kanda Yurie, Miyagawa Ippei, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), May 2025, Reviewed, No invitation

TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus.
Shan Yu, Nakayamada Shingo, Nawata Aya, Yamagata Kaoru, Sonomoto Koshiro, Tanaka Hiroaki, Satoh-Kanda Yurie, Nguyen Mai-Phuong, Todoroki Yasuyuki, Nagayasu Atsushi, Ueno Masanobu, Kanda Ryuichiro, Fujita Yuya, Zhang Tong, Hao He, Zhou Jieqing, Ma Xiaoxue, Anan Junpei, Nguyen Anh Phuong, Tanaka Yoshiya
Rheumatology (Oxford, England), 2023, Reviewed, No invitation

Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
Todoroki Yasuyuki, Kubo Satoshi, Nakano Kazuhisa, Miyazaki Yusuke, Ueno Masanobu, Satoh-Kanda Yurie, Kanda Ryuichiro, Miyagawa Ippei, Hanami Kentaro, Nakatsuka Keisuke, Saito Kazuyoshi, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), Mar. 2022, Reviewed, No invitation

Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosis.
Kubo Satoshi, Nakayamada Shingo, Miyazaki Yusuke, Yoshikawa Maiko, Yoshinari Hiroko, Satoh Yurie, Todoroki Yasuyuki, Nakano Kazuhisa, Satoh Minoru, Smith Vanessa, Cutolo Maurizio, Tanaka Yoshiya
Rheumatology (Oxford, England), Jun. 2019, Reviewed, No invitation

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Kanda Ryuichiro, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Satoh-Kanda Yurie, Ohkubo Naoaki, Todoroki Yasuyuki, Tanaka Hiroaki, Ueno Masanobu, Nagayasu Atsushi, Fujita Yuya, Aritomi Takafumi, Kusaka Katsuhide, Sakai Hidenori, Matsunaga Satsuki, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, Mar. 2025, Reviewed, No invitation

Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
Ohkubo Naoaki, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Inoue Yoshino, Satoh-Kanda Yurie, Tanaka Hiroaki, Todoroki Yasuyuki, Miyata Hiroko, Nagayasu Atsushi, Funada Masashi, Kobayashi Hiroki, Sakai Hidenori, Kosaka Shumpei, Matsunaga Satsuki, Tomoyose Yukiko, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, Oct. 2024, Reviewed, No invitation